In situ oxygen-producing nanoplatform inducing multifunctional cell death for enhanced photodynamic therapy of hypoxic tumors
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Photodynamic Therapy Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (50)
Show source-provided references
1. Engineering photodynamics for treatment, priming and imaging10.1038/s44222-024-00196-z ↗
2. Modulation of tumor hypoxia and redox microenvironment using nanomedicines for enhanced cancer photodynamic therapy
3. Luminescent, oxygen-supplying, hemoglobin-linked conjugated polymer nanoparticles for photodynamic therapy10.1002/anie.201905884 ↗
4. Innovative strategies for enhanced tumor photodynamic therapy10.1039/D1TB01466H ↗
5. Conquering the hypoxia limitation for photodynamic therapy10.1002/adma.202103978 ↗
6. Innovative strategies for hypoxic-tumor photodynamic therapy10.1002/anie.201805138 ↗
7. Engineering a theranostic platform for synergistic hypoxia-responsive photodynamic therapy and chemotherapy10.1016/j.matt.2022.02.019 ↗
8. Pt nanozyme-bridged covalent organic framework-aptamer nanoplatform for tumor targeted self-strengthening photocatalytic therapy10.1016/j.biomaterials.2023.122109 ↗
9. Nanozyme for tumor therapy: surface modification matters10.1002/EXP.20210005 ↗
10. Photodynamic therapy for hypoxic tumors: advances and perspectives
11. Copper/gold-modified porphyrinic metal–organic frameworks nanoprobes for enhanced photodynamic/chemodynamic therapy
12. Persistent regulation of tumor hypoxia microenvironment via a bioinspired Pt-based oxygen nanogenerator for multimodal imaging-guided synergistic phototherapy
13. Nanomaterial-related hemoglobin-based oxygen carriers, with emphasis on liposome and nano-capsules, for biomedical applications: current status and future perspectives10.1186/s12951-024-02606-1 ↗
14. High intensity focused ultrasound-responsive and ultrastable cerasomal perfluorocarbon nanodroplets for alleviating tumor multidrug resistance and epithelial–mesenchymal transition
15. Biogenic nanobubbles for effective oxygen delivery and enhanced photodynamic therapy of cancer10.1016/j.actbio.2020.03.034 ↗
16. Prussian blue modified metal organic frameworks for imaging guided synergetic tumor therapy with hypoxia modulation10.1016/j.jallcom.2020.157329 ↗
17. Metallic 1T phase enabling MoS(2) nanodots as an efficient agent for photoacoustic imaging guided photothermal therapy in the near-infrared-II window10.1002/smll.202004173 ↗
18. FTO deficiency in older livers exacerbates ferroptosis during ischaemia/reperfusion injury by upregulating ACSL4 and TFRC10.1038/s41467-024-49202-3 ↗
19. Construction of Fe-doped ZIF-8/DOX nanocomposites for ferroptosis strategy in the treatment of breast cancer10.1039/D3TB00749A ↗
20. A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy
21. Ferroptosis: an iron-dependent form of nonapoptotic cell death10.1016/j.cell.2012.03.042 ↗
22. Regulation of ferroptotic cancer cell death by GPX410.1016/j.cell.2013.12.010 ↗
23. Self-cascade nanohybrids boost cell ferroptosis stress for tumor radiosensitization therapy
24. Metal-organic framework-based nanomedicines for ferroptotic cancer therapy10.1002/adhm.202303533 ↗
25. System Xc(-): a key regulatory target of ferroptosis in cancer, Invest10.1007/s10637-021-01070-0 ↗
26. A forward vision for chemodynamic therapy: issues and opportunities10.1002/anie.202210415 ↗
27. Nanozyme-enhanced ferroptosis for cancer treatment10.1039/D3QM01202F ↗
28. CuS/Co-Ferrocene-MOF nanocomposites for photothermally enhanced chemodynamic antibacterial therapy10.1021/acsanm.4c02067 ↗
29. Current status of Fe-based MOFs in biomedical applications10.1039/D3MD00416C ↗
30. Deciphering aromaticity in porphyrinoids via adaptive natural density partitioning10.1039/C4OB01018C ↗
31. Glycosylated porphyrins, phthalocyanines, and other porphyrinoids for diagnostics and therapeutics10.1021/acs.chemrev.5b00244 ↗
32. A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy10.1016/j.jconrel.2022.06.019 ↗
33. Synthesis of copper peroxide nanodots for H(2)O(2) self-supplying chemodynamic therapy10.1021/jacs.9b03457 ↗
34. Light-triggered nanozymes remodel the tumor hypoxic and immunosuppressive microenvironment for ferroptosis-enhanced antitumor immunity10.1021/acsnano.4c00844 ↗
35. Metal-organic frameworks with enhanced photodynamic therapy: synthesis, erythrocyte membrane camouflage, and aptamer-targeted aggregation10.1021/acsami.0c04363 ↗
36. Nanotrains of DNA copper nanoclusters that triggered a cascade fenton-like reaction and glutathione depletion to doubly enhance chemodynamic therapy10.1021/acsami.2c05944 ↗
37. Preparation of dye molecule-intercalated MoO(3) organic/inorganic superlattice nanoparticles for fluorescence imaging-guided catalytic therapy10.1002/smll.202200595 ↗
38. A dual heat shock protein down-regulation strategy using PDA/Cu/ICG/R controlled by NIR "switch" enhances mild-photothermal therapy effect
39. Fasciola gigantica thioredoxin glutathione reductase: biochemical properties and structural modeling
40. Mitochondrial dysfunction: mechanisms and advances in therapy10.1038/s41392-024-01839-8 ↗
41. GSH-responsive nanoprodrug to inhibit glycolysis and alleviate immunosuppression for cancer therapy10.1021/acs.nanolett.1c03089 ↗
42. ROS-Drp1-mediated mitochondria fission contributes to hippocampal HT22 cell apoptosis induced by silver nanoparticles10.1016/j.redox.2023.102739 ↗
43. Combination of disulfiram and copper−cysteamine nanoparticles induces mitochondria damage and promotes apoptosis in endometrial cancer
44. Ferroptosis10.1016/j.cub.2020.09.068 ↗
45. Superoxide dismutase-like regulated Fe/Ppa@PDA/B for synergistically targeting ferroptosis/apoptosis to enhance anti-tumor efficacy10.1002/adhm.202301824 ↗
46. Iron-doxorubicin prodrug loaded liposome nanogenerator programs multimodal ferroptosis for efficient cancer therapy
47. Multiphoton fluorescence microscopy for in vivo imaging10.1016/j.cell.2024.07.036 ↗
48. Engineering dual-responsive prodrug-MOFs as immunogenic cell death initiator for enhancing cancer immunotherapy10.1002/adhm.202302333 ↗
49. The mechanisms of nanoparticle delivery to solid tumours10.1038/s44222-024-00154-9 ↗
50. Activating layered metal oxide nanomaterials via structural engineering as biodegradable nanoagents for photothermal cancer therapy